A complete solution for rapid molecular diagnostics of coronavirus infection

With its two complementary platform technologies Amplidiag® and Novodiag®, Mobidiag has the capacity to meet the needs of clinical laboratories and multiple healthcare settings. Currently on the market, these platforms combine high quality and affordable costs, allowing widespread use both in mass screening and on-demand highly targeted or syndromic tests for various infectious diseases. The extremely versatile product offer, the flexibility of the technologies used, and the expertise of the Mobidiag team allow great responsiveness in the development of new products in emergency situations. Rapid molecular diagnostics of coronavirus infection currently offered by Mobidiag in the case of the COVID-19 pandemic are a perfect example.

Since December 2019, COVID-19 has been spreading rapidly throughout the World. You can follow live evolution of the infection on the WHO Coronavirus Disease (COVID-19) Dashboard.

Choose the right coronavirus test based on your needs

Novodiag® COVID-19 Amplidiag® COVID-19
Product no. NVD-CV-012 AD-CV-864
Package size 12 cartridges 864 tests
Sample type Nasopharyngeal swab Nasopharyngeal swab
Technology RT-PCR RT-PCR
Targets SARS-CoV-2 (orf1ab)
SARS-CoV-2 (N)
SARS-CoV-2 (orf1ab)
SARS-CoV-2 (N)
Time to results About 1h 55min for amplification
<3h when using Amplidiag® Easy platform
Benefits Two molecular targets to mitigate against the effects of genetic drift and avoid cross-reaction with other endemic coronavirus
On demand testing
Fast
Easy to use
Fully automated
Low hands-on time (<5min)
Closed system ensuring healthcare professionals's safety
Two molecular targets to mitigate against the effects of genetic drift and avoid cross-reaction with other endemic coronavirus
Large volumes on batches
Automated process for DNA extraction and PCR set up with Amplidiag® Easy platform
Availability CE-IVD CE-IVD

Mobidiag offers 2 complementary molecular tests for rapid molecular diagnostics of coronavirus infection: Novodiag® COVID-19 and Amplidiag® COVID-19 . To provide optimal performance, both of these molecular assays have been designed using dual targets of SARS-CoV-2 (orf1ab & N genes) to include at least one conserved region and one specific region to mitigate against the effects of genetic drift and avoid cross-reaction with other endemic coronavirus.

Amplidiag® COVID-19 and Novodiag® COVID-19 are now CE-IVD. Please contact us for more information.

Please note that Mobidiag tests are not home testing kits. As a result, they are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Key Advantages

- A complete solution for rapid and reliable molecular diagnostics of coronavirus infection
- A test for all sample volumes
- Self-sufficient in production and securing of raw materials to ensure continuity of testing throughout the complete workflow, from sample collection to results

Dedicated tests

A complete solution for rapid diagnostics of coronavirus infection
Novodiag COVID-19

Novodiag® COVID-19

CE-IVD

Novodiag® COVID-19 test operates using the on demand rapid ‘sample-in, result-out’ Novodiag® system, allowing the rapid detection of novel coronavirus in about 1 hour.
This fully automated solution protects laboratory staff from potential contamination. With its user-friendly nature, the Novodiag® COVID-19 solution can be delivered to high risk and hard to reach areas, as well as decentralized laboratories, without the need for highly trained personnel.
This qualitative real-time RT-PCR test supports decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care globally.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Contact sales@mobidiag.com or fill in the form below for more information and orders.

A complete solution for rapid diagnostics of coronavirus infection
Novodiag COVID-19

Amplidiag® COVID-19

CE-IVD

Amplidiag® COVID-19 test allows the rapid detection of novel coronavirus for large volumes (by batch). By allowing rapid and reliable detection of this novel coronavirus, this qualitative real-time RT-PCR test supports decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care globally.

Please note that Mobidiag tests are not home testing kits. They are only available for healthcare professionals, and not for patients directly. Based on your location, follow the recommended process if you believe you could be infected by SARS-CoV-2.

Contact sales@mobidiag.com or fill in the form below for more information and orders.